The Role of Quantification of Glucocorticoid-associated Toxicity in Severe Asthma.
作者信息
McDowell P J, Stone J H, Heaney L G
机构信息
Centre for Experimental Medicine, School of Medicine, Dentistry, and Biological Sciences; Queen's University Belfast, Northern Ireland, UK.
Division of Rheumatology, Allergy, & Clinical Immunology, Massachusetts General Hospital,Harvard Medical School, USA.
出版信息
J Cell Immunol. 2021;3(1):31-35. doi: 10.33696/immunology.3.074.
Abstract
摘要
相似文献
1
The Role of Quantification of Glucocorticoid-associated Toxicity in Severe Asthma.糖皮质激素相关毒性定量在重度哮喘中的作用
J Cell Immunol. 2021;3(1):31-35. doi: 10.33696/immunology.3.074.
2
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index.使用糖皮质激素毒性指数定量评估严重哮喘患者的糖皮质激素相关并发症。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):365-372.e5. doi: 10.1016/j.jaip.2020.08.032. Epub 2020 Sep 1.
3
Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma.重度哮喘中非肌肉型丝切蛋白-1的表达与类固醇反应性
J Allergy Clin Immunol. 2006 Nov;118(5):1090-6. doi: 10.1016/j.jaci.2006.07.039. Epub 2006 Sep 25.
4
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.度普利尤单抗治疗糖皮质激素依赖型重症哮喘的疗效和安全性。
N Engl J Med. 2018 Jun 28;378(26):2475-2485. doi: 10.1056/NEJMoa1804093. Epub 2018 May 21.
5
Glucocorticoid receptor-binding characteristics in severe asthma.
Eur Respir J. 2003 Jun;21(6):985-8. doi: 10.1183/09031936.03.00059802.
6
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.贝那鲁肽在重症哮喘中的糖皮质激素节省作用。
N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22.
7
Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma.
Mayo Clin Proc. 1996 Apr;71(4):361-8. doi: 10.4065/71.4.361.
8
Impact of Gene Expression Associated with Glucocorticoid-Induced Transcript 1 (GLCCI1) on Severe Asthma and Future Exacerbation.GLCCI1 基因表达与糖皮质激素诱导转录 1 对严重哮喘和未来加重的影响。
Biol Pharm Bull. 2019 Oct 1;42(10):1746-1752. doi: 10.1248/bpb.b19-00476. Epub 2019 Aug 6.
9
Glucocorticoid-resistant asthma: more than meets the eye.糖皮质激素抵抗性哮喘：远不止表面所见。
J Asthma. 2013 Dec;50(10):1036-44. doi: 10.3109/02770903.2013.831870. Epub 2013 Sep 25.
10
Asthma refractory to glucocorticoids: the role of newer immunosuppressants.糖皮质激素难治性哮喘：新型免疫抑制剂的作用
Am J Respir Med. 2002;1(1):47-54. doi: 10.1007/BF03257162.
引用本文的文献
1
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry.重度哮喘伴/不伴慢性鼻-鼻窦炎伴鼻息肉患者使用口服糖皮质激素的费用：来自意大利SANI注册研究的数据
Adv Ther. 2025 Feb;42(2):1196-1206. doi: 10.1007/s12325-024-03071-w. Epub 2025 Jan 4.
2
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.关于系统性糖皮质激素治疗嗜酸性粒细胞相关疾病的专家共识。
Front Immunol. 2024 Jan 5;14:1310211. doi: 10.3389/fimmu.2023.1310211. eCollection 2023.
本文引用的文献
1
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index.使用糖皮质激素毒性指数定量评估严重哮喘患者的糖皮质激素相关并发症。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):365-372.e5. doi: 10.1016/j.jaip.2020.08.032. Epub 2020 Sep 1.
2
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma.静脉注射瑞利珠单抗治疗口服皮质类固醇依赖型哮喘的疗效。
J Allergy Clin Immunol Pract. 2020 Feb;8(2):555-564. doi: 10.1016/j.jaip.2019.09.036. Epub 2019 Oct 15.
3
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial.使用贝那利珠单抗治疗嗜酸性粒细胞性哮喘时的糖皮质激素减量：PONENTE试验
ERJ Open Res. 2019 Sep 25;5(3). doi: 10.1183/23120541.00009-2019. eCollection 2019 Jul.
4
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study.全身性皮质类固醇激素用于哮喘治疗引发的不良后果：长期观察性研究。
J Asthma Allergy. 2018 Aug 29;11:193-204. doi: 10.2147/JAA.S176026. eCollection 2018.
5
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature.长期口服皮质类固醇治疗对成人严重哮喘的影响及其副作用：对文献中影响数据的重点回顾。
Eur Respir J. 2018 Oct 25;52(4). doi: 10.1183/13993003.00703-2018. Print 2018 Oct.
6
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.度普利尤单抗在中重度未控制哮喘中的疗效和安全性。
N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21.
7
Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.英国哮喘患者口服皮质类固醇的不良事件概况：队列研究与巢式病例对照分析。
Respir Res. 2018 Apr 27;19(1):75. doi: 10.1186/s12931-018-0742-y.
8
Age and Sex Associations with Systemic Corticosteroid-Induced Morbidity in Asthma.年龄和性别与哮喘中全身皮质类固醇诱导的发病率的相关性。
J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2014-2023.e2. doi: 10.1016/j.jaip.2018.04.008. Epub 2018 Apr 21.
9
Asthma.哮喘。
Lancet. 2018 Feb 24;391(10122):783-800. doi: 10.1016/S0140-6736(17)33311-1. Epub 2017 Dec 19.
10
"I have lost in every facet of my life": the hidden burden of severe asthma.“我在生活的方方面面都失败了”：严重哮喘的隐性负担。
Eur Respir J. 2017 Sep 20;50(3). doi: 10.1183/13993003.00765-2017. Print 2017 Sep.
Zotero 插件